Literature DB >> 24779452

Ketamine cystitis: practical considerations in management.

Saumya Misra1, Andrew Chetwood, Charles Coker, Philip Thomas.   

Abstract

OBJECTIVE: The aim of this study was to investigate and report the clinical spectrum and practical problems in the management of a cohort of patients presenting with lower urinary tract symptoms (LUTS) related to abuse of ketamine.
MATERIAL AND METHODS: The clinical presentation, cystoscopic findings, radiological features and outcomes of patients presenting with LUTS related to ketamine abuse between January 2008 and April 2013 were retrospectively reviewed and analysed.
RESULTS: In total, 34 patients were seen during this period. All patients had LUTS, haematuria and abdominal pain to varying degrees. Two patients (7%) had a concomitant urinary tract infection. Upper tract imaging was carried out in 18 out of 34 patients and bilateral hydronephrosis was found in two cases (6%). Cystoscopy showed a small inflamed bladder (capacity 60-350 ml) in 14 out of the 16 cases where this was performed. Bladder biopsies showed denudation of urothelium and infiltration of submucosa with lymphocytes and eosinophils with no increase in mast cells. Fifty-nine per cent of patients did not attend their clinic, imaging and/or cystoscopy appointments. One patient underwent a subtotal cystectomy and bladder reconstruction.
CONCLUSIONS: Ketamine cystitis is a complex problem whose exact pathological mechanism and natural history remain unknown. The only known effective treatment is to abstain from the drug. Urologists need to recognize the condition early and work together with the local substance misuse service, focusing on drug cessation therapy to reduce complications.

Entities:  

Keywords:  bladder; cystitis; ketamine

Mesh:

Substances:

Year:  2014        PMID: 24779452     DOI: 10.3109/21681805.2014.909530

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  5 in total

1.  Autotransplantation for the management of ketamine ureteritis.

Authors:  Nicholas Tobias Johannes Raison; Timothy O'Brien; David Game; Jonathon Olsburgh
Journal:  BMJ Case Rep       Date:  2015-04-09

2.  Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.

Authors:  Aram Kim; Hwan Yeul Yu; Jinbeom Heo; Miho Song; Jung-Hyun Shin; Jisun Lim; Soo-Jung Yoon; YongHwan Kim; Seungun Lee; Seong Who Kim; Wonil Oh; Soo Jin Choi; Dong-Myung Shin; Myung-Soo Choo
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

3.  Epidemiologic characteristics and risk factors in patients with ketamine-associated lower urinary tract symptoms accompanied by urinary tract infection: A cross-sectional study.

Authors:  Weihua Liu; Weiwei Wu; Yongbao Wei; Jinfeng Wu; Tao Li; Qingguo Zhu; Liefu Ye; Fuyuan Hong; Yunliang Gao; Jinrui Yang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy.

Authors:  Chi-Hang Yee; Jeremy Yuen-Chun Teoh; Pui-Tak Lai; Vivian Yee-Fong Leung; Winnie Chiu-Wing Chu; Wai-Man Lee; Yuk-Him Tam; Chi-Fai Ng
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

5.  Dysuria due to benign prostatic hyperplasia of the median lobe with ketamine-associated uropathy in a young male.

Authors:  Zhangcheng Liao; Zhao Wang; Zhongyuan Jin; Zhengyan Tang
Journal:  BMC Urol       Date:  2019-10-30       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.